21.20.Z - Manufacture of medicines and other pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical substances
32.50.Z - Manufacture of medical and dental instruments and supplies
72.19.Z - Other research and experimental development on natural sciences and engineering
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Assets | 3,9 | 4,4 | 3,9 | -11,5 |
Profit (loss) on sale | 0,1 | 0,4 | 0,3 | -25,6 |
Gross profit (loss) | 0,1 | 0,3 | 0,3 | 8,2 |
Net profit (loss) | 0,1 | 0,2 | 0,3 | 11,4 |
Cash | 1 | 0,8 | 0,5 | -38,1 |
Liabilities and provisions for liabilities | 1,4 | 1,7 | 1,3 | -18,9 |
Net income from sale | 4,1 | 4,4 | 4,1 | -7,8 |
Short time liabilities | 1,4 | 1,7 | 1,3 | -18,9 |
Other operating costs | 0 | 0 | 0 | -46,7 |
Working assets | 2,6 | 3,2 | 2,7 | -13,9 |
Equity capital | 2,5 | 2,7 | 2,5 | -7 |
Other income costs | 0 | -0,1 | 0 | 130,4 |
Operating profit (EBIT) | 0,1 | 0,3 | 0,3 | 8,2 |
% | % | % | p.p. | |
Profitability of capital | 3,2 | 9 | 10,8 | 1,8 |
Equity capital to total assets | 63,5 | 62,2 | 65,3 | 3,1 |
Gross profit margin | 2,2 | 6,4 | 7,5 | 1,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 127 | 137 | 121 | -16 |
Current financial liquidity indicator | 1.8502272367477417 | 1.9163286685943604 | 2.033456802368164 | 0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane